DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury

Podocyte loss and progressive glomerular injury in type II diabetes.

Maria Enrica Pagtalunan, Paul L. Miller, S Jumping-Eagle et al. · Journal of Clinical Investigation · 1997 · 1.1K citations · Full text

Medicine, Nephrology, Pathology +17

Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.

Bryant P. Bullock, R. Scott Heller, Joel F. Habener · Endocrinology · 1996 · 590 citations

Life Sciences, Endocrinology, Physiology +16

Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen

Keizo Kanasaki, Sen Shi, Megumi Kanasaki et al. · Diabetes · 2014 · 368 citations · Full text

Medicine, Nephrology, Pharmacology +17

Role of TGF-<b><i>β</i></b>Pathway Polymorphisms in Sporadic Thoracic Aortic Aneurysm: rs900 TGF-<b><i>β</i></b>2 Is a Marker of Differential Gender Susceptibility

Letizia Scola, Federica Maria Di Maggio, M Bova et al. · Mediators of Inflammation · 2014 · 358 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.

R V Campos, Y C Lee, Daniel J. Drucker · Endocrinology · 1994 · 345 citations

Life Sciences, Endocrinology, Molecular Biology +10